Navigation Links
Personalized Stem Cells, Inc. Sponsors Arthritis Foundation Event in Los Angeles
Date:11/27/2019

Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, recently sponsored an event put on by the Arthritis Foundation and hosted by Dr. Steven Sampson and Dr. Danielle Aufiero of the Orthohealing Center in Los Angeles, California. The event, which took place on October 23, 2019, highlighted the ongoing efforts to promote research, educate the public, and provide support to people with arthritis.

Event attendees included medical doctors, physical therapists, chiropractors, and other medical professionals. Dr. Sampson presented current and evolving regenerative and stem cell therapies, including PSC’s FDA approved clinical trial to treat osteoarthritis in the knee with a person’s own stem cells. The Orthohealing Center is one of several approved clinical trial sites and is currently screening and enrolling patients in the clinical trial.

PSC CEO, Michael Dale, stated, “It is an honor to help support the Arthritis Foundation and to work closely with the Orthohealing Center. The Foundation and the Orthohealing Center have worked together for many years advocating and spreading awareness for arthritis patients.”

PSC provides stem cell therapy for clinical trial investigators and their patients, working within the FDA cell therapy regulations in order to assure consistent manufacturing, quality tested cells, as well as clinical trial and manufacturing oversite for safety and efficacy. PSC was founded by Robert Harman, DVM, MPVM and Michael Dale, both of whom also co-founded VetStem Biopharma and are both experienced serial entrepreneurs.

About Personalized Stem Cells, Inc.
Personalized Stem Cells was formed in 2018 to advance and legitimize human regenerative medicine. This privately held biopharmaceutical enterprise, based near San Diego (California), offers qualified physicians who enroll, an FDA compliant autologous stem cell product (from patient’s own fat tissue) for use in FDA approved clinical trials. PSC is driving development and adoption of stem cell and regenerative medicine within the FDA-IND process by providing cGMP manufactured, quality tested cells, and well-defined clinical trials. PSC has licensed a portfolio of over 70 issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/personalized_stem_cells_inc_sponsors_arthritis_foundation_event_in_los_angeles/prweb16748973.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Personalized Stem Cells, Inc. Announces First Patients Treated in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
2. Personalized Stem Cells, Inc. Announces First Patients Enrolled in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
3. VetStem Biopharma Secures FDA Approval of First Human IND for its Subsidiary, Personalized Stem Cells, Inc.
4. Personalized Stem Cells, Inc. Announces FDA Approval of IND Application for Treatment of Osteoarthritis with Stem Cells
5. Personalized Medicine: A New Approach to Treat Periodontal Diseases
6. Zipongo Incorporates 23andMe Reports Into Personalized Nutrition Plans
7. Personalized Medicine - Scientific and Commercial Aspects - 318 Companies Profiled with 575 Collaborations - Research and Markets
8. NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology
9. @USANAincs Personalized Nutrition Program Wins Industry Innovation Award
10. "Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014
11. Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/14/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell ... for stem cell treatment of knee osteoarthritis . The first treatment came shortly after ... Biopharma. , In July of 2019, PSC received FDA approval for a ...
(Date:11/12/2019)... Ohio (PRWEB) , ... November ... ... Products , a global leader in the design and manufacturer of technical ... of seating and adjustable footrests compliant with Healthier Hospital Initiative guidelines. Established ...
(Date:11/12/2019)... ... November 12, 2019 , ... The ... nonprofit U.S. universities and research institutions for its Instrumentation Grant for Advanced ... to $1.2 million per site for the acquisition of instrumentation, development and maintenance; ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... November 12, 2019 , ... Peggy Lillis Foundation (PLF) ... deadly healthcare-associated infection C. diff. The campaign, “See C. diff,” combines ... at least 30,000 people in the U.S. each year. The campaign also features ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... off-the-record collaboration and dialogue, today announces its East/West CEO conference to ... San Francisco. , Kicking off the week of the J.P. Morgan ...
(Date:11/5/2019)... ... ... was demonstrating signs of osteoarthritis in April 2019. He was lame and stiff and ... play were normal, it was clear that he was in pain. , Ole’s owner took ... Center in San Diego, California. Dr. Mullen is an experienced VetStem user and ...
(Date:11/2/2019)... ... October 31, 2019 , ... ... artificial intelligence pioneer tellic. drug360 brings tellic’s expertise in biomedical language processing ... researchers to quickly uncover relationships between genes, diseases, variants, phenotypes, and other biomedical ...
Breaking Biology Technology: